The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index, and 1 are not checked yet; 15 of the 51 sources its claims cite were checked for support.
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Open accessAbstract
Substantial data indicate that microRNA 21 (miR-21) is significantly elevated in glioblastoma (GBM) and in many other tumors of various origins. This microRNA has been implicated in various aspects of carcinogenesis, including cellular proliferation, apoptosis, and migration. We demonstrate that miR-21 regulates multiple genes associated with glioma cell apoptosis, migration, and invasiveness, including the RECK and TIMP3 genes, which are suppressors of malignancy and inhibitors of matrix metalloproteinases (MMPs). Specific inhibition of miR-21 with antisense oligonucleotides leads to elevated levels of RECK and TIMP3 and therefore reduces MMP activities in vitro and in a human model of gliomas in nude mice. Moreover, downregulation of miR-21 in glioma cells leads to decreases of their migratory and invasion abilities. Our data suggest that miR-21 contributes to glioma malignancy by downregulation of MMP inhibitors, which leads to activation of MMPs, thus promoting invasiveness of cancer cells. Our results also indicate that inhibition of a single oncomir, like miR-21, with specific antisense molecules can provide a novel therapeutic approach for "physiological" modulation of multiple proteins whose expression is deregulated in cancer.
Verified 2026-10-19 · 1 reference not checked yet
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
miR-21 is elevated in high-grade gliomas and promotes glioma invasion by directly targeting the MMP inhibitor RECK and indirectly regulating TIMP3, leading to increased MMP activity. Inhibiting miR-21 raises RECK/TIMP3, reduces MMP activity in vitro and in vivo, and decreases glioma cell motility and invasion, partly rescued by RECK knockdown.
Key findings
- miR-21 levels remain low in grade II gliomas and most grade III tumors but are significantly higher in GBMs; RECK mRNA is significantly lower in GBMs than normal brain and grade II/III gliomas, and TIMP3 mRNA tends to be lower in GBMs.
- Anti-miR-21 treatment changed expression of ∼570 genes (P < 0.05); upregulated transcripts were enriched for miR-21 seed hexamers (expectations 1.45e−09, 1.37e−14, and 1.82e−12), and at least 65 mRNAs were upregulated by anti-miR-21 and downregulated by miR-21 overexpression.
- miR-21 inhibition increased RECK mRNA ∼2-fold and TIMP3 mRNA about 1.6-fold; RECK was validated as a direct miR-21 target by luciferase reporter, whereas TIMP3 was not consistently directly responsive and is likely downstream.
- miR-21 inhibition reduced MMP-2 activity in A172 and U87 cells and lowered MMP activity in U87 subcutaneous tumors in nude mice; it also reduced scratch motility and Matrigel invasion, with reduced motility partly rescued by RECK siRNA and reduced invasion not observed when anti-miR-21 was cotransfected with RECK siRNA.
Methods
- Human glioma cell lines A172, U87, and LN229 (high miR-21), plus HeLa, MCF7, and U2OS cells, and human nonneoplastic brain and tumor samples; cells were transfected with 2′-O-MOE anti-miR-21, mismatch/control oligonucleotides, synthetic miR-21 duplex, or RECK siRNA.
- mRNA profiling used Agilent 44K arrays at 6 and 24 h posttreatment, with qRT-PCR, Western blot, luciferase 3′ UTR reporter assays with mutated miR-21 binding sites, gelatin zymography, scratch migration, and Matrigel invasion assays.
- In vivo, U87 cells transfected with anti-miR-21 or control were implanted subcutaneously in nude mice; MMP activity was imaged with MMPSense 680 at 3 days after implantation and 24 h later, with caliper tumor measurements.
Limitations
- Stated by the authors: the 2′-O-MOE anti-miR-21 did not significantly or consistently change glioma cell viability or reduce subcutaneous U87 tumor growth; subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized, so they are not an accurate model for studying invasiveness and tumor growth; nucleic acid chemistry can profoundly alter cellular responses to miRNA inhibition; therapeutic potential requires future research.
- Stated/evident from the text: the TIMP3 3′ UTR reporter did not consistently respond to miR-21 changes, so TIMP3 is likely a downstream effector rather than a direct target; RECK protein bands were not detectable by Western blot in U87 cells despite ∼2-fold RECK mRNA upregulation.
- Evident from the text: in vivo imaging was performed within the first week, when anti-miR-21 did not affect subcutaneous U87 tumor growth; comparison with a prior intracranial LNA-DNA anti-miR-21 study is limited because tumor locations differed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 of 51 cited sources checked · 11 supported · 0 flagged · accuracy not yet measured
Every source the paper cites for this claim was checked and supports it.
In the paper
“Among the molecules tested, the 2′-O-MOE ASO was the most potent in repressing miR-21 activity (Fig. 2A), in agreement with previous data (10), whereas the uniform 2′-O-methyl ASO was the least potent, and mixed locked nucleic acid (LNA)-DNA oligonucleotides were variable (data not shown).”
What the sources say
- Supportedcites [10] source
The Discussion explicitly identifies the uniformly modified 2′-O-MOE-PO oligonucleotide as the best anti-miRNA ASO tested. This supports the attributed comparison for miR-21 activity, although the passage specifies the oligonucleotide’s backbone as PO. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Concurring with previously published reports (12, 46), our data indicate that these MMP inhibitors regulate MMP activity posttranslationally.”
What the sources say
- Supportedcites [12] source
The paper describes TIMPs as inhibitors of metalloproteinase activity and shows that TIMP-3 controls the cell-surface activation of pro-MMP-2 (Abstract and Discussion; page numbers unavailable). Its gene-expression analysis found comparable MMP-2 levels in wild-type and TIMP-3-deficient cells despite altered processing, supporting regulation after translation. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [46] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, we have not detected any correlation between miR-21-modulated expression in several glioma cell lines and protein level of phosphatase and tensin homolog (data not shown), the reported miR-21 target in hepatocellular carcinomas (44).”
What the sources say
- Supportedcites [44] source
The citation supports the identification of PTEN as a reported miR-21 target in hepatocellular carcinoma: the Results state that PTEN was shown to be a direct target of miR-21 in HCC cells. The preceding statement about no correlation in glioma cell lines is the citing authors’ own unpublished observation, not a finding attributed to this source. (LLM, conf=0.94)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our data suggest that this can be at least partly due to miR-21 regulation, in addition to the reported chromosome 12q22-23 loss of heterozygosity and hypermethylation (56).”
What the sources say
- Partly supportedcites [56] Watanabe T., 2003, Brain Pathol. sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports chromosome 12q22–23 loss of heterozygosity in glioblastomas and its association with low Apaf-1 expression. It mentions hypermethylation only as a possible mechanism in some malignancies; the reported study did not measure it in glioblastomas. The miR-21 proposal is presented as the citing authors’ own conclusion, not as a finding attributed to this source. (LLM, conf=0.83)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In gliomas, APAF1 is often inactivated or downregulated (56).”
What the sources say
- Partly supportedcites [56] Watanabe T., 2003, Brain Pathol. sourceExperimental — accuracy not yet measured
The Abstract reports low APAF1 mRNA and protein expression in many glioblastomas with chromosome 12q22–23 loss of heterozygosity. The study examined glioblastoma, however, so it does not establish that APAF1 is often inactivated or downregulated across gliomas generally. (LLM, conf=0.85)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The numbers of invasive A172 and U87 cells in cultures with inhibited miR-21 were significantly reduced relative to those in cultures transfected with the control oligonucleotide (Fig. 7A and B).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Specific inhibition of miR-21 with antisense oligonucleotides leads to elevated levels of RECK and TIMP3 and therefore reduces MMP activities in vitro and in a human model of gliomas in nude mice.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, downregulation of miR-21 in glioma cells leads to decreases of their migratory and invasion abilities.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“RECK mRNA expression was significantly lower in GBMs than in normal brain tissue and, especially, in grade II and III gliomas.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When miR-21 was suppressed, the amount of gelatin digested that reflects the levels of MMP-2 proteolytic activity was significantly reduced relative to the amount for the cells transfected with the control oligonucleotide (Fig. 5A).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 28
- Probably not a substantial claim. 21
- The quote only partly states this claim. 2
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Accumulated data suggested that MMP levels and activities are significantly elevated in human gliomas, which contributes to glioma cell invasion of the surrounding normal tissues, metastasis, and angiogenesis through cell surface ECM degradation (21, 45).”
What the sources say
- Not checked — no full text of the sourcecites [21] Hu B., 2003, Proc. Natl. Acad. Sci. USA source
- Partly supportedcites [45] sourceExperimental — accuracy not yet measured
The Abstract and §4.1 link elevated MMP levels in human gliomas to invasiveness, and describe ECM degradation and cell-surface activation. But the Abstract discusses metastasis in cancer generally, not specifically gliomas; §4.2 links MMP-9 to angiogenesis only tentatively and says its activity in invasive glioma tissue is unproven. The copy therefore does not establish significantly elevated MMP activities across human gliomas or the claimed glioma metastasis and angiogenesis mechanism. Page numbers were not supplied. (LLM, conf=0.88)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“TIMP3 is a tissue inhibitor of MMPs that inhibits angiogenesis and tumor cell infiltration and also induces apoptosis (2, 48).”
What the sources say
- Partly supportedcites [2] sourceExperimental — accuracy not yet measured
The paper’s Summary (p. 1347) identifies TIMP-3 as a tissue inhibitor of metalloproteinases, and its discussion reports inhibited invasion of HeLa and HT1080 cancer cells and apoptotic death in three cancer cell lines. The copy does not report that TIMP-3 inhibits angiogenesis; searches for angiogenesis and blood-vessel formation found no supporting passage. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [48] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This microRNA has been implicated in various aspects of carcinogenesis, including cellular proliferation, apoptosis, and migration.”
- Also stated in: § Abstract · plain
“miR-21 has been identified in controlling apoptosis, cell proliferation, and migration of cell lines in breast, colorectal, and other cancers (1, 44, 51, 59).”
What the sources say
- Not checked — no full text of the sourcecites [1] source
- Supportedcites [44] source
The Results report that changing miR-21 expression affects proliferation and migration in HCC cells. The Discussion also reports anti-apoptotic properties of miR-21 in glioblastoma and cholangiocarcinoma, supporting the broader statement that it has been implicated in all three processes. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [51] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Also stated in: § Abstract · plain
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our analysis also confirmed tropomyosin 1 (TPM1) regulation by miR-21, previously reported to occur in MCF7 cells (59, 60).”
What the sources say
- Supportedcites [59] source
The Abstract reports that experiments using tumors derived from MCF-7 cells identified TPM1 as a miR-21 target and confirmed that miR-21 down-regulates its expression. The Results section also reports increased endogenous TPM1 in anti-miR-21-treated, MCF-7-derived tumors. The paper therefore supports the cited prior report, although its tumor measurements were made in MCF-7-derived tumors rather than isolated cells. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [60] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Another factor that can induce miR-21 expression is hypoxia, a general feature of all solid tumors (30).”
What the sources say
- Supportedcites [30] source
The Results report miR-21 among the hypoxia-regulated microRNAs and say its microarray result was checked by quantitative RT-PCR. The introductory passage describes hypoxia as an essential feature of the neoplastic microenvironment. (LLM, conf=0.90)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The miR-21 gene contains two conserved STAT3 binding sites within its enhancer region and is induced by interleukin 6 (IL-6) in a STAT3-dependent way.”
What the sources say
- Supportedcites [39] source
The Results and discussion section identifies two conserved Stat3 binding sites in the miR-21 upstream regulatory region. It also reports that IL-6 increased miR-21 expression and that Stat3 knockdown inhibited this induction. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“MMPs can degrade ECM components and therefore play important roles in mediating GBM tumor cell motility and invasion (45).”
What the sources say
- Supportedcites [45] source
The Introduction says MMPs can degrade nearly all ECM macromolecules in the brain and are believed to play a major role in tumor invasion. The Abstract links MMP-mediated ECM degradation to glioblastoma invasion, while Section 4 describes how ECM degradation may permit glioma-cell migration. (LLM, conf=0.92)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“APAF1 (apoptotic protease activating factor 1) is the molecular core of apoptosome. It is typically required for activation of the caspases that initiate apoptosis (3, 26).”
What the sources say
- Supportedcites [3] source
The Introduction describes Apaf-1 oligomerization as forming the apoptosome, while the Results and discussion state that Apaf-1 normally recruits and activates caspases-9 and -3. The Concluding remarks add that caspase-9 activity depends on interaction with oligomerized Apaf-1. Page numbers are not provided in our copy. (LLM, conf=0.90)
- Supportedcites [26] Johnson C. E., 2007, Proc. Natl. Acad. Sci. USA source
The paper’s introductory discussion (page not specified in our copy) says cytochrome c binds Apaf-1, leading to recruitment of procaspase-9 and formation of the apoptosome; the apoptosome then activates caspase-9. In the section on Apaf-1 expression levels (page not specified), adding Apaf-1 enabled cytochrome c to activate caspases in neural extracts, supporting its required role in the pathway described. (LLM, conf=0.91)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Elevated miR-21 expression has been causally linked to proliferation, apoptosis, and migration of several cancer cell lines (1, 5, 44, 60).”
What the sources say
- Not checked — no full text of the sourcecites [1] source
- Not checked — no full text of the sourcecites [5] source
- Supportedcites [44] source
The Results report that experimentally increasing or inhibiting miR-21 changed proliferation and migration in HCC cell lines. The Discussion reports anti-apoptotic properties of miR-21 in glioblastoma and cholangiocarcinoma, supporting the apoptosis part as a finding the paper reports from other studies. (LLM, conf=0.87)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“miR-21 levels remain low in grade II gliomas and in most grade III tumors and are significantly higher in GBMs (Fig. 1).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This expression pattern is different from those of the other cancer-associated miRNAs, for example, miR-10b, which is often elevated in grade III and even grade II gliomas (Fig. 1) and dysregulated in some other cancers (41).”
What the sources say
- Not checked — no full text of the sourcecites [41] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“RECK mRNA level increased consistently ∼2-fold and TIMP3 mRNA about 1.6-fold in the cells transfected with anti-miR-21.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These experiments demonstrated that inhibition of miR-21 reduced the motility of glioma cells (Fig. 6B and C).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“We note that, though 2′-O-MOE miR-21 ASO induced many proapoptotic and cell cycle arrest genes (Fig. 2C; also see Table S1 in the supplemental material), it did not significantly and consistently change the viability of glioma cell lines, which was reported for other, less potent miR-21 inhibitors (5, 8).”
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“STAT3, the other gene that may play a tumor suppressor function in GBM (11), is also negatively regulated by miR-21 according to the microarray data (see Table S1 in the supplemental material) and is a predicted miR-21 target (29, 34).”
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As identified in our study, TIMP3 or both TIMP3 and RECK are also induced by anti-miR-21 in MCF7 (breast carcinoma) and U2OS (osteosarcoma) cells (Fig. 4D).”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In glioma progression from less invasive grade II gliomas to very invasive GBMs, RECK and TIMP3 levels drop (Fig. 4B), whereas miR-21 expression increases (Fig. 1).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here, we show that a 2′-O-MOE ASO not only is potent but also upregulates miR-21 seed-containing mRNAs (Fig. 2 and 3).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Substantial data indicate that microRNA 21 (miR-21) is significantly elevated in glioblastoma (GBM) and in many other tumors of various origins.”
- Also stated in: § Abstract · boosted
“Using high-throughput profiling of miRNA expression, we have previously identified a specific miRNA, miRNA 21 (miR-21), as most strongly elevated in nearly all analyzed human GBM specimens (5).”
- Also stated in: § Abstract · boosted
“Other groups demonstrated overexpression of this miRNA in a wide range of other cancers, including breast, lung, colon, prostate, pancreas, ovarian, and stomach cancers, as well as in chronic lymphocytic leukemia (33, 54).”
What the sources say
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Abstract · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“mRNAs carrying RECK and TIMP3 are predicted conserved miR-21 targets with one and two putative binding sites, respectively (Fig. 4A).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The sequences of the control and mismatch oligonucleotides have been analyzed using BLAST searches to exclude potential hits in the human transcriptome.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“RECK is a membrane-anchored MMP inhibitor whose reduced expression or inactivation seems to be critical for the invasiveness and metastasis of various cancers, including glioma cancer (7, 46).”
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The high level of miR-21 expression in GBMs compared to that in anaplastic astrocytomas suggests the involvement of miR-21 in one of these key processes.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
In the paper
“Its expression level is also an important prognostic factor for multiple cancer types (6).”
What the sources say
- Not checked — no full text of the sourcecites [6] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“It has been demonstrated to inhibit MMP activity and tumor growth in malignant gliomas in vivo (31, 32).”
What the sources say
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Since modified oligonucleotides can induce a wide range of nonspecific, off-target-mediated effects, several ASO molecules of different chemistries have been used for miR-21 inhibition.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our data suggest that miR-21 contributes to glioma malignancy by downregulation of MMP inhibitors, which leads to activation of MMPs, thus promoting invasiveness of cancer cells.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such overrepresentation of the hexamers suggests an abundance of direct miR-21 targets among the genes upregulated by 2′-O-MOE anti-miR-21 and indicates that the effects of this molecule on glioma cells are indeed mediated through the miR-21 pathway.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“These experiments have been performed with the miR-21 inhibitor and with a mismatched control oligonucleotide to ensure that any observed effects are driven by miR-21.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“Importantly, it inhibits tumor necrosis factor alpha-converting enzyme and induces apoptosis through the stabilization of tumor necrosis factor alpha receptors on the cell surface (42).”
What the sources say
- Not checked — no full text of the sourcecites [42] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, it leads to reduction of glioma cell motility and invasion, which is mediated by elevated RECK expression and was partly rescued by RECK siRNA (Fig. 6 and 7).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This implies that miR-21 regulates RECK and TIMP3 expression and thus MMP activities and glioma tumor invasiveness.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this study, we have demonstrated in vitro and in vivo, using U87 glioma xenografts in nude mice, that miR-21 regulates MMPs and glioma cell invasiveness by directly controlling the MMP inhibitor RECK.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These combined results indicate that miR-21 regulates overlapping though not identical sets of genes in different cells and therefore shares common signaling pathways in different cancers.”
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The APAF1 3′ UTR contains a strong miR-21 binding site (9-mer binding at miR-21 5′ end), and therefore, it is likely one of the direct miR-21 targets.”
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Its expression is highly upregulated in a variety of solid tumors, including GBM, breast, lung, colon, prostate, pancreas, and stomach cancers (5, 54).”
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our mRNA expression analysis suggests that miR-21 regulates the expression of multiple mRNA targets and thereby induces several cellular programs in glioma cells, including those associated with the tumor invasiveness and microvascular proliferation typical for the GBM as well as those involved in cell cycle regulation and apoptosis.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Its ectopic expression in glioma cells induces upregulation of genes associated with angiogenesis, growth factors, cytokines, death receptors, and substrates of the various MMPs (31).”
What the sources say
- Not checked — no full text of the sourcecites [31] Lam P., 2005, Mol. Ther. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“RECK, a membrane-anchored regulator, and TIMP3, the ECM-bound protease regulator, are key inhibitors of several MMPs, and their expression is prognostic in a number of common cancers (28, 53).”
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“TIMP3 has been demonstrated to activate caspases and therefore induce apoptosis of human glioma cells in vitro and the growth inhibition of human glioma tumors in a mouse model (31, 32).”
What the sources say
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Though mRNA expression analysis does not allow identification of targets whose translation is regulated without modulation of mRNA levels”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Such a bidirectional approach to manipulating miR-21 levels enabled narrowing of the lists of regulated genes and identification of those whose expression correlated negatively with miR-21 levels”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In these experiments, we used tumorigenic U87 cells, a common model of human gliomas (23).”
What the sources say
- Not checked — no full text of the sourcecites [23] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
MMPs are a group of peptidases involved in degradation of the ECM.
“MMPs are a group of peptidases involved in degradation of the ECM.”
The paper relies on this without support.
Subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized.
“We should also note that subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized.”
The paper relies on this without support.
Knowledge of the molecular mechanisms mediating miR-21 function in cancer generally and in gliomas specifically is limited.
“However, our knowledge of the molecular mechanisms mediating miR-21 function in cancer generally and gliomas specifically is limited.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“miR-21 is a well-known miRNA, found to be overexpressed in almost all cancer types, where its upregulation promotes cell proliferation, invasion, and metastatic behavior.”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have proven that PDCD4, HNRNPK and RECK are TSGs among the direct targets of miR-21-5p (13,(27)(28)(29).”
From Functional interaction between miR-505-3p and miR-21 contributes to GBM suppression (2026) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“miR-21 targets several genes such as PDCD4, TIMP3, and RECK, which are key regulators of apoptotic and metastatic pathways (17–23).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Our data on the effects of miR-21 enriched exosomes is in agreement with the previous reports demonstrating that overexpressed miR-21 in cell lines can increase the proliferation rate and malignant behavior of the cells (17–23).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
APAF1 overexpression claim cites a caspase-8 study
MinorIn the APAF1 discussion, the paper attributes apoptosis induced by viral overexpression to APAF1 and cites reference 50. The cited reference instead describes adenovirus-mediated transfer of caspase-8 in combination with a superrepressor of NF-kappaB.
“Its overexpression by viral transduction induces apoptosis in glioma cells and may be beneficial in glioma treatment (50).”
“50.Shinoura, N., N. Yamamoto, Y. Yoshida, A. Asai, T. Kirino, and H. Hamada. 2000. Adenovirus-mediated transfer of caspase-8 in combination with superrepressor of NF-kappaB drastically induced apoptosis in gliomas.”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,837
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Self-citationIn vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Liang, C.-C., Park, A. Y., & Guan, J.-L. (2007) · Nature Protocols · doi:10.1038/nprot.2007.30 · Cited by 4,696
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Flagged first, then by citations
Research works printed but not linked: 1
- Gao F., 2007, Oncol. Rep., 17, 123
Cited by
Sorted by citations
Items 101–200 of 886
Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma
Rao, S. A., Santosh, V., & Somasundaram, K. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.135 · Cited by 181
Tomimaru, Y., Eguchi, H., Nagano, H., Wada, H., Tomokuni, A., Kobayashi, S., Marubashi, S., Takeda, Y., Tanemura, M., Umeshita, K., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605958 · Cited by 178
“…MMPs expression (by negative regulation of tissue inhibitor of metalloproteinases 3 (TIMP3) and reversion-inducing cysteine-rich protein with Kazal motifs (RECK)) and that MMPs levels correlated significantly with chemosensitivity (Gabriely et al, 2008; Almendro et al, 2009; Song et al, 2009).”
BackgroundEpigenetic mechanisms in glioblastoma multiforme
Nagarajan, R. P., & Costello, J. F. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.02.005 · Cited by 176
MiRNA-451 plays a role as tumor suppressor in human glioma cells
Yang, N., Han, L., Zhang, A., Wang, G., Jia, Z., Yang, Y., Yue, X., Pu, P., Zhong, Y., & Kang, C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.074 · Cited by 176
MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation
Li, Q., Zhang, D., Wang, Y., Sun, P., Hou, X., Larner, J., Xiong, W., & Mi, J. (2013) · Scientific Reports · doi:10.1038/srep02038 · Cited by 179
From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer
Rhim, J., Baek, W., Seo, Y., & Kim, J. H. (2022) · Cells · doi:10.3390/cells11182791 · Cited by 192
Regulation of microRNAs in cancer metastasis
Bouyssou, J., Manier, S., Huynh, D., Issa, S., Roccaro, A. M., & Ghobrial, I. M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.02.002 · Cited by 176
Quintavalle, C., Garofalo, M., Zanca, C., et al. (2011) · Oncogene · doi:10.1038/onc.2011.280 · Cited by 174
“In particular, inhibition of miR-21 reduces motility and invasiveness of glioma cells through the regulation of RECK, a membrane-anchored matrix metalloproteinase inhibitor important for extracellular matrix (ECM) remodeling (Gabriely et al., 2008).”
MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications
Stahlhut, C. E., & Slack, F. J. (2013) · Genome Medicine · doi:10.1186/gm516 · Cited by 176
“miR-21 has been identified as being upregulated in glioblastomas, and miR-21 knockdown in glioblastoma cell lines results in caspase activation and elevated apoptotic rates, indicating a pro-survival function for miR-21 [44-48].”
BackgroundYamamichi, N., Shimomura, R., Inada, K.-I., Sakurai, K., Haraguchi, T., Ozaki, Y., Fujita, S., Mizutani, T., Furukawa, C., Fujishiro, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3257 · Cited by 175
Loss of Brain-enriched miR-124 MicroRNA Enhances Stem-like Traits and Invasiveness of Glioma Cells
Xia, H., Cheung, W. K. C., Ng, S. S., Jiang, X., Jiang, S., Sze, J., Leung, G., Lü, G., Chan, D. T. M., Bian, X., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.332627 · Cited by 177
MicroRNA in Glioblastoma: An Overview
Banelli, B., Forlani, A., Allemanni, G., Morabito, A., Pistillo, M. P., & Romani, M. (2017) · International Journal of Genomics · doi:10.1155/2017/7639084 · Cited by 171
“Several miRNAs are involved in EMT or in general into the mechanisms of invasion; they include miR-21, miR-146, miR-10b, and miR-7 that target directly or indirectly metalloproteinase inhibitors [84, 85], adhesion molecules, and other genes involved in metastasis and cell invasion [86–88].”
BackgroundmiR-182 as a Prognostic Marker for Glioma Progression and Patient Survival
Jiang, L., Mao, P., Song, L., Wu, J., Huang, J., Lin, C., Yuan, J. X., Qu, L., Cheng, S., & Li, J. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090812 · Cited by 167
MicroRNA-21 is involved in osteosarcoma cell invasion and migration
Wu, Z., Shuhua, Y., Xiufang, W., & Xiaoyun, L. (2010) · Medical Oncology · doi:10.1007/s12032-010-9563-7 · Cited by 167
“MG-63 cells by PCR using the forward primers ATTAA CTAGTACCTCTATTCGCCACACAG and the reverse primers CTACATCAGCACTGACATATTCTG [ 20 ].”
MethodResultMicroarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury
Lei, P., Li, Y., Chen, X., Yang, S., & Zhang, J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.074 · Cited by 193
“…physiological or pathological processes, with little reported study focus on miRNAs at acute injury pathological conditions (El et al., 2008; Gabriely et al., 2008; Giraldez et al., 2006; Hornstein et al., 2005; Kajimoto et al., 2006; Pekarsky et al., 2006; Sayed et al., 2008; Zhu et al.,…”
BackgroundMicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma
Liu, C., Yu, J., Yu, S., Lavker, R. M., Cai, L., Liu, W., Yang, K.-G., He, X., & Chen, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.021 · Cited by 165
“MiR-21 regulates HCC cell invasiveness by targeting PTEN [14], and RECK is another miR21 target that is associated with glioma cell invasiveness [16].”
BackgroundMicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches
Callegari, E., Gramantieri, L., Domenicali, M., D’Abundo, L., Sabbioni, S., & Negrini, M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.136 · Cited by 167
MicroRNA-Based Therapeutics for Cancer
Wang, V., & Wu, W. (2009) · BioDrugs · doi:10.2165/00063030-200923010-00002 · Cited by 161
Zhang, H., Qi, M., Li, S., Qi, T., Mei, H., Huang, K., Zheng, L., & Tong, Q. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0001 · Cited by 158
“tumor suppressor genes, such as tissue inhibitor of metalloproteinase 3 (6), phosphatase, and tensin homolog deleted on chromosome 10 (7), tropomyosin 1 (8),”
BackgroundGwak, H., Kim, T. H., Jo, G. H., Kim, Y., Kwak, H., Kim, J. H., Yin, J., Yoo, H., Lee, S. H., & Park, J. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047449 · Cited by 160
“various cellular responses including anti-apoptotic events, tumor growth, and chemo-resistance [10–16].”
BackgroundMicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1
Hunt, S., Jones, A. V., Hinsley, E. E., et al. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.11.038 · Cited by 154
“ECM components may be regulated by specific microRNAs (miRNAs) [5].”
BackgroundMicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4
Schramedei, K., Mörbt, N., Pfeifer, G., Läuter, J., Rosołowski, M., Tomm, J. M., von Bergen�, M., Horn, F., & Brocke-Heidrich, K. (2011) · Oncogene · doi:10.1038/onc.2011.15 · Cited by 159
“To date, experimentally confirmed targets include multiple tumor suppressive components of the p53, TGF-b and mitochondrial apoptosis pathways (Papagiannakopoulos et al., 2008), as well as tumor suppressors PDCD4 (Asangani et al., 2008), PTEN (Meng et al., 2007), RECK (Gabriely et al., 2008), TPM1 (Zhu et al., 2008) a…”
BackgroundInfluentialMelkamu, T., Zhang, X., Tan, J., Zeng, Y., & Kassie, F. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp208 · Cited by 152
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro
Rey, C., Nadjar, A., Buaud, B., Vaysse, C., Aubert, A., Pallet, V., Layé, S., & Joffre, C. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.013 · Cited by 166
Guo, Y.-W., Hong, W., Wang, X., Zhang, P., Körner, H., Tu, J., & Wei, W. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00125 · Cited by 153
“In glioma cells, miR-21 exerted its oncogenic effects by promoting invasion (Gabriely et al., 2008) and repressing apoptosis (Quintavalle et al.”
BackgroundDownregulation of Spry2 by miR-21 triggers malignancy in human gliomas
Kwak, H.-J., Kim, Y.-J., Chun, K.-R., Woo, Y. M., Park, S.-J., Jeong, J.-A., Jo, S. H., Kim, T. H., Min, H. S., Chae, J. S., et al. (2011) · Oncogene · doi:10.1038/onc.2010.620 · Cited by 151
“Recently, it was reported that glioma invasion is induced by increased miR-21 expression, but the mechanism by which this occurs remains unclear (Gabriely et al., 2008).”
BackgroundVillar, A. V., García, R., Merino, D., Llano, M., Cobo, M., Montalvo, C., Martín‐Durán, R., Hurlé, M. A., & Nistal, J. F. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.07.021 · Cited by 150
“In addition, somemiR-21 targets validated in extracardiac tissues [29], such as reversion-inducing-cysteine-rich protein with kazal motifs (RECK) and the tissue inhibitor of metalloproteinase 3 (TIMP3), play key roles in the control of the ECM homeostasis [30,31] which deserve further attention in the scenario of huma…”
BackgroundGao, P., Xing, A.-Y., Zhou, G.-Y., Zhang, T.-G., Zhang, J.-P., Gao, C., Li, H., & Shi, D.-B. (2012) · Oncogene · doi:10.1038/onc.2012.61 · Cited by 150
“7--9,11,24 Cell growth may also have an effect on the process of metastasis, for example by taking part in the final step of metastasis colonization.”
RetractedCurrent Progress on Understanding MicroRNAs in Glioblastoma Multiforme
Karsy, M., Arslan, E., & Moy, F. (2012) · Genes & Cancer · doi:10.1177/1947601912448068 · Cited by 151
“Furthermore, inhibition of miR-21 in xenografted GBM tumors downregulated the activity of various MMPs (3, 9, 7, 12, and 13), reduced in vitro motility, and diminished invasion compared to sham miR inhibition.(57) A promising study by Ren et al.”
BackgroundMicroRNAs as biomarkers for CNS cancer and other disorders
Smaele, E. D., Ferretti, E., & Gulino, A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.103 · Cited by 154
“A similar role in glioblastoma stem cells has been described for mR-124, miR-137 and miR-451 (Gal et al., 2008; Godlewski et al., 2008, 2009; Silber et al., 2008).”
Dai, X., & Tan, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.010 · Cited by 149
Aigner, A. M. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0716-0 · Cited by 147
Coppola, V., Maria, R. D., & Bonci, D. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0172 · Cited by 152
“2008) and the metalloprotease inhibitors TIMP3 and RECK (Gabriely et al. 2008).”
BackgroundMicroRNA involvement in glioblastoma pathogenesis
Nováková, J., Slabý, O., Vyzula, R., & Michálek, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.034 · Cited by 141
“rect target of miR-21 seems to be only RECK, however, the expression level of TIMP3 also decreases as the level of miR-21 increases [13].”
BackgroundJiang, L., Lin, C., Song, L., Wu, J., Chen, B., Ying, Z., Fang, L., Xiao, Y., He, M., Li, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58849 · Cited by 145
Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy
Wang, Y., Gan, G., Wang, B., Wu, J., Cao, Y., Zhu, D., Xu, Y., Wang, X., Han, H., Li, X., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.02.019 · Cited by 149
“This technology helps to compensate for normal movement of the internal organs due to breathing and for changes occurring in cancer size during treatment, thereby reducing unnecessary doses to normal tissues (Gabriely et al., 2008).”
BackgroundUncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma
Sun, J., Gong, X. Q., Purow, B. W., & Zhao, Z. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002488 · Cited by 144
Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma
Tomaselli, S., Galeano, F., Alon, S., Raho, S., Galardi, S., Polito, V. A., Presutti, C., Vincenti, S., Eisenberg, E., Locatelli, F., et al. (2015) · Genome biology · doi:10.1186/s13059-014-0575-z · Cited by 145
“Interestingly, we observed that the rescue of active ADAR2 in glioblastoma cells (U118) results in the down-regulation of a large number of miRNAs (Additional file 3), including three important onco-miRNAs (miR-221, miR-222 and miR-21), which play a pivotal role in cancer progression and are found particularly over-ex…”
BackgroundEffect of miR-21 on Renal Fibrosis by Regulating MMP-9 and TIMP1 in kk-ay Diabetic Nephropathy Mice
Wang, J., Gao, Y., Ma, M.-F., Li, M., Zou, D., Yang, J., Zhu, Z., & Zhao, X. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9539-2 · Cited by 144
Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity
Keller, P., Gburcik, V., Petrovič, N., Gallagher, I. J., Nedergaard, J., Cannon, B., & Timmons, J. A. (2011) · BMC Endocrine Disorders · doi:10.1186/1472-6823-11-7 · Cited by 141
“found that downregulation of mir-21 in glioma cells reduces their invasive potential, probably by relieving mir-21 targeting of metalloprotease inhibitors, allowing metallo proteases to be active [57].”
BackgroundMicroenvironmental regulation of cancer metastasis by miRNAs
Zhang, Y., Yang, P., & Wang, X. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.09.007 · Cited by 139
Chen, Y., Luo, L., Bai, X., Shen, K., Liu, K., Wang, J., & Hu, D. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108259 · Cited by 141
MicroRNA-21 in Glomerular Injury
Lai, J. Y., Luo, J., O'Connor, C. L., Jing, X., Nair, V., Ju, W., Randolph, A. E., Ben‐Dov, I. Z., Matar-Ujvary, R., Briskin, D., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121274 · Cited by 143
Hurst, D. R., & Welch, D. R. (2011) · International review of cytology · doi:10.1016/b978-0-12-385859-7.00003-3 · Cited by 140
MicroRNAs in skin and wound healing
Banerjee, J., Chan, Y. C., & Sen, C. K. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00157.2010 · Cited by 139
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
Shu, M., Zheng, X., Wu, S., Lu, H., Leng, T., Zhu, W., Zhou, Y., Ou, Y., Lin, X., Lin, Y., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-59 · Cited by 139
“Current therapies for astrocytomas including surgery, radiation, and chemotherapy have not been successful due to the rapid and invasive tumor growth, the genetic heterogeneity and our poor understanding of the molecular mechanisms governing disease manifestation and progression [2].”
BackgroundGliomas display a microRNA expression profile reminiscent of neural precursor cells
Lavon, I., Zrihan, D., Granit, A., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop061 · Cited by 135
Yan, W., Zhang, W., Sun, L., Liu, Y., You, G., Wang, Y., Kang, C., You, Y., & Jiang, T. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.002 · Cited by 135
“AndMMP-9might also be used as prognostic markers in patients with sinonasal and oral malignant melanoma (Kondratiev et al., 2008).”
miRNAs regulate expression and function of extracellular matrix molecules
Rutnam, Z. J., Wight, T. N., & Yang, B. B. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.11.003 · Cited by 134
“…miR-146b Glioblastoma Xia et al. (2009) MMP-16 miR-31 Breast cancer Valastyan et al. (2009) TIMP3 miR-21 Breast cancer and cholangiocarcinomas Gabriely et al. (2008), Selaru et al. (2009) TIMP3 miR-181, −181b Heptaocellular carcinoma Wang et al. (2010b) TIMP3 miR-221, −222 Small cell lung…”
BackgroundCancer stem cell contribution to glioblastoma invasiveness
Ortensi, B., Setti, M., Osti, D., & Pelicci, G. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt166 · Cited by 137
“Recently, GBMs have been shown to contain microvesicles carrying angiogenic proteins and inhibitors of MMPs, of EGFRvIII mRNA, and of miRNA-21, res ponsible for GBM invasion [102,127].”
BackgroundBullock, M. D., Pickard, K., Nielsen, B. S., Sayan, E., Jenei, V., Mellone, M., Mitter, R., Primrose, J. M., Thomas, G. J., Packham, G., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.213 · Cited by 133
“RECK mRNA has been shown to be targeted directly by miR21 in mutated/unmutated 30-untranslated region luciferase reporter assays in several cell lines and in numerous tumour contexts.(17,26) We found that stable miR-21-expressing fibroblasts express reduced RECK mRNA and protein Figure 1 (a) ISH of representative CRC…”
Let-7 microRNA inhibits the proliferation of human glioblastoma cells
Lee, S.-T., Chu, K., Oh, H.-J., Im, W., Lim, J., Kim, S.-K., Park, C.-K., Jung, K.-H., Lee, S.-K., Kim, M., et al. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0286-6 · Cited by 138
“Thus, knockdown of miR-21 with antagomir increases glioblastoma apoptosis [19], and reduces migratory and invasion ability of the cells, suggesting therapeutic implications [ 23 ].”
BackgroundLong non-coding RNA in glioma: signaling pathways
Shi, J. Y., Dong, B., Cao, J., Mao, Y., Guan, W., Peng, Y., & Wang, S. (2017) · Oncotarget · doi:10.18632/oncotarget.15175 · Cited by 134
“A growing body of literature has shown that knockdown of miR-21 inhibits tumorigenesis by regulating multiple factors associated with cell proliferation, migration, invasion and apoptosis [86, 87].”
BackgroundMiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2
Wang, X., Shi, Z., Wang, X.-R., Cao, L., Wang, Y., Zhang, J., Yin, Y., Luo, H., Kang, C., Liu, N., et al. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1114-x · Cited by 132
“For instance, miR-21 is over-expressed in gliomas and a number of other tumor types (Calin and Croce 2006) and targets a wide variety of genes involved in cell motility, migration, and apoptosis, such as PTEN, PDCD4, and TM1 (Chan et al. 2005; Gabriely et al. 2008; Zhu et al. 2008; Qi et al. 2009; Qian et al. 2009).”
BackgroundKey Matrix Remodeling Enzymes: Functions and Targeting in Cancer
Piperigkou, Z., Kyriakopoulou, K., Koutsakis, C., Mastronikolis, S. N., & Karamanos, N. K. (2021) · Cancers · doi:10.3390/cancers13061441 · Cited by 136
MicroRNA‐214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells
Yang, Z., Chen, S., Luan, X., et al. (2009) · IUBMB Life · doi:10.1002/iub.252 · Cited by 131
Radiation-Induced Micro-RNA Modulation in Glioblastoma Cells Differing in DNA-Repair Pathways
Chaudhry, M. A., Sachdeva, H., & Omaruddin, R. A. (2010) · DNA and Cell Biology · doi:10.1089/dna.2009.0978 · Cited by 131
“Oncomir miR-21 regulates RECK and TIMP3 genes associated with glioma cell apoptosis, migration, and invasiveness and are inhibitors of matrix metalloproteinases (Gabriely et al. , 2008). miR-21 target genes include HNRPK and TAp63 .”
Effect of miR-142-3p on the M2 Macrophage and Therapeutic Efficacy Against Murine Glioblastoma
Xu, S., Wei, J., Wang, F., Kong, L.-Y., Ling, X.-Y., Nduom, E. K.-E., Gabrusiewicz, K. R., Doucette, T. A., Yang, Y., Yaghi, N. K., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju162 · Cited by 132
“MicroRNAs (miRNAs) are noncoding molecules involved in post-transcriptional gene regulation that have been shown to modulate tumor cell proliferation and apoptosis and to act as oncogenes or tumor-suppressor genes (1,2).”
BackgroundClinical applications of microRNAs
Hydbring, P., & Badalian‐Very, G. (2013) · F1000Research · doi:10.12688/f1000research.2-136.v3 · Cited by 175
Reis, S. T., Pontes‐Júnior, J., Antunes, A. A., Dall’Oglio, M. F., Dip, N., PASSEROTTI, C. C., Rossini, G. A., Morais, D. R., Nesrallah, A., Piantino, C. B., et al. (2012) · BMC Urology · doi:10.1186/1471-2490-12-14 · Cited by 129
“Additionally, it has been shown that inhibition of miR-21 results in reduced MMP activity leading to reduction of cell motility and invasiveness, through increased expression of RECK [14].”
BackgroundGlioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
Jhanwar‐Uniyal, M., LaBagnara, M., Friedman, M., Kwasnicki, A. M., & Murali, R. (2015) · Cancers · doi:10.3390/cancers7020538 · Cited by 130
High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
Zhang, C., Zhang, J., Hao, J., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-119 · Cited by 126
“MiR-21 is an important oncogenic miRNA that promotes cell invasion by regulating multiple genes, including PTEN, RECK and MARCKS in several kinds of cancers, such as glioma, ovarian epithelial carcinoma and prostate cancer [5-7].”
BackgroundMicroRNAs in colorectal cancer metastasis
de Krijger, I., Mekenkamp, L. J., Punt, C. J. A., & Nagtegaal, I. D. (2011) · The Journal of Pathology · doi:10.1002/path.2922 · Cited by 126
The effects of environmental chemical carcinogens on the microRNA machinery
Izzotti, A., & Pulliero, A. (2014) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2014.01.001 · Cited by 126
Monfared, H., Jahangard, Y., Nikkhah, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00782 · Cited by 123
Ru, P., Steele, R., Hsueh, E. C., et al. (2011) · Genes & Cancer · doi:10.1177/1947601911425832 · Cited by 122
Dynamically regulated miRNA-mRNA networks revealed by exercise
Tonevitsky, A., Maltseva, D. V., Abbasi, A., Samatov, T. R., Sakharov, D. A., Shkurnikov, M. Y., Lebedev, A. E., Galatenko, V., Grigoriev, A. I., & Northoff, H. (2013) · BMC Physiology · doi:10.1186/1472-6793-13-9 · Cited by 125
“PDGFD encodes for platelet derived growth factor D [33], a member of the platelet-derived growth factor family which can regulate many cellular processes, including cell proliferation, apoptosis, transformation, migration,”
BackgroundAltered expression of miRNA‐21 and its targets in the hippocampus after traumatic brain injury
Redell, J. B., Zhao, J., & Dash, P. K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22539 · Cited by 121
“In addition, the mRNA expression levels of at least seven additional predicted target genes (CPEB3, GLCCL1, PELI1, PLEKHA1, SOX2, STAT3, and YOD1) were inversely regulated by the overexpression or inhibition of miR-21 in A172 glioma cells (Gabriely et al., 2008).”
BackgroundInfluentialHe, Y., Cui, Y., Wang, W., Gu, J. F., Guo, S., Ma, K., & Luo, X. (2011) · Neoplasia · doi:10.1593/neo.11698 · Cited by 120
“TIMP3 plays a functional role in the lysophosphatidic acid (LPA)–induced invasion [34], andmiR-21/ miR-221 and 222 can also regulate TIMP3 expression [35,36].”
Oncogenic role of microRNAs in brain tumors
Pang, J. C.-S., Kwok, W. K., Chen, Z., & Ng, H.-K. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0525-0 · Cited by 101
Yao, Q., Cao, S., Li, C., Mengesha, A., Kong, B., & Wei, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25506 · Cited by 121
Chen, L., Han, L., Zhang, K., Shi, Z., Zhang, J., Zhang, A., Wang, Y., Song, Y., Li, Y., Jiang, T., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos122 · Cited by 118
MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review
Ahir, B. K., Ozer, H., Engelhard, H. H., & Lakka, S. S. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.10.003 · Cited by 120
Smits, M., Mir, S. E., Nilsson, R. J. A., van der Stoop, P. M., Niers, J. M., Marquez, V. E., Cloos, J., Breakefield, X. O., Krichevsky, A. M., Noske, D. P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016282 · Cited by 118
Self-citationSmall molecules with big effects: The role of the microRNAome in cancer and carcinogenesis
Koturbash, I., Zemp, F. J., Pogribny, I. P., & Kovalchuk, O. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.05.006 · Cited by 119
Gaffney, J. P., Solomonov, I., Zehorai, E., & Sagi, I. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.012 · Cited by 117
Extracellular matrix dynamics in cell migration, invasion and tissue morphogenesis
Yamada, K. M., Collins, J. W., Walma, D. A. C., Doyle, A. D., Morales, S. R. G., Lu, J., Matsumoto, K., Nazari, S., Sekiguchi, R., Shinsato, Y., et al. (2019) · International Journal of Experimental Pathology · doi:10.1111/iep.12329 · Cited by 124
The role of microRNAs in metastasis and epithelial-mesenchymal transition
Bracken, C. P., Gregory, P. A., Khew‐Goodall, Y., & Goodall, G. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8750-1 · Cited by 119
Lutz, B. M., Bekker, A., & Tao, Y. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000265 · Cited by 117
Li, X., Wang, H.-Z., Wu, Z.-W., Yang, T., Zhao, Z., Chen, G., Xie, X., Li, B., Wei, Y., Huang, Y., et al. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0163-0 · Cited by 115
“Cumulative evidences indicate that miRNAs regulate diverse biologic processes such as cell migration, invasion, proliferation, identity, apoptosis, stress resistance, and stem cell maintenance (Gabriely et al. 2008; Hwang and Mendell 2006).”
BackgroundNanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma
Seo, Y.-E., Suh, H., Bahal, R., Josowitz, A. D., Zhang, J., Song, E., Cui, J., Noorbakhsh, S. I., Jackson, C. B., Bu, T., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.02.016 · Cited by 112
Foxo3a Regulates Apoptosis by Negatively Targeting miR-21
Wang, K., & Li, P.-F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093005 · Cited by 117
MicroRNAs, diet, and cancer: New mechanistic insights on the epigenetic actions of phytochemicals
Parasramka, M. A., Ho, E., Williams, D. E., & Dashwood, R. H. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20822 · Cited by 115
“[89,90] or downregulated by miR-181b, miR-146b [91,92].”
MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
Chen, D., Cabay, R. J., Jin, Y., Wang, A., Lu, Y., Shah-Khan, M., & Zhou, X. C. (2013) · Journal of Oral and Maxillofacial Research · doi:10.5037/jomr.2013.4102 · Cited by 113
“A large number of target genes for miR-21 have been identified and experimentally confirmed, and most of them are established tumour suppressors (e.g., PTEN [41], PDCD4 [40], Tropomyosin [46], Sprouty 1 and 2 [47,48], Bcl2 [49], RECK [50], JAG1 [51], HNRPK [46], TGFBRII [52], P12/CDK2AP1 [53], MEF2C [54], RhoB [55] an…”
BackgroundmirConnX: condition-specific mRNA-microRNA network integrator
Huang, G., Athanassiou, C. G., & Benos, P. V. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr276 · Cited by 114
Connolly, E. C., Doorslaer, K. V., Rogler, L. E., & Rogler, C. E. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0465 · Cited by 118
“(9) showed that miR-21 promotes glioma migration and invasion through targeting of matrix metalloproteinase (MMP) inhibitors.”
BackgroundVickers, M. M., Bar, J., Gorn‐Hondermann, I., Yarom, N., Daneshmand, M., Hanson, J. E. L., Addison, C., Asmis, T. R., Jonker, D. J., Maroun, J. A., et al. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9435-3 · Cited by 114
Ferraro, A., Kontos, C. K., Boni, T., Bantounas, I., Siakouli, D., Kosmidou, V., Vlassi, M., Spyridakis, Y., Tsipras, I., Zografos, G., et al. (2014) · Epigenetics · doi:10.4161/epi.26842 · Cited by 111
Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology
Binzel, D. W., Shu, Y., Li, H., Sun, M., Zhang, Q., Shu, D., Guo, B., & Guo, P. (2016) · Molecular Therapy · doi:10.1038/mt.2016.85 · Cited by 111
The role of extracellular vesicle microRNAs in cancer biology
Takahashi, R., Prieto‐Vila, M., Hironaka, A., & Ochiya, T. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0708 · Cited by 114
microRNAs in Spinal Cord Injury: Potential Roles and Therapeutic Implications
Ning, B., Gao, L., Liu, R., Liu, Y., Zhang, N., & Chen, Z. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9058 · Cited by 109
Emerging functions of microRNAs in glioblastoma
Lawler, S. E., & Chiocca, E. A. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9843-2 · Cited by 108
“This showed that in addition to regulating apoptosis, miR-21 may also promote invasion by direct targeting and downregulation of metalloprotease inhibitors including TIMP3 and RECK [ 56 ].”
BackgroundRole of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis
Ghaemmaghami, A. B., Mahjoubin‐Tehran, M., Movahedpour, A., Morshedi, K., Sheida, A., Taghavi, S. P., Mirzaei, H., & Hamblin, M. R. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00623-9 · Cited by 108
Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Wang, Q. Z., Xu, W., Habib, N., & Xu, R. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788486731 · Cited by 111
Regulation of Breast Cancer and Bone Metastasis by MicroRNAs
Vimalraj, S., Miranda, P. J., Ramyakrishna, B., & Selvamurugan, N. (2013) · Disease Markers · doi:10.1155/2013/451248 · Cited by 110
The role of microRNAs in glioma initiation and progression
Zhang, Y. (2011) · Frontiers in bioscience · doi:10.2741/3952 · Cited by 109
“In the second publication, the authors used a multidimensional genomic data set of glioblastoma from TCGA to identify miR-26a as a cooperating component of a frequently occurring amplicon that also contains CDK4 and CENTG1, two oncogenes that regulate the RB1 and PI3K/AKT pathways, respectively.”
BackgroundInfluentialReduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3
Kang (2010) · Oncology Reports · doi:10.3892/or_00000846 · Cited by 107
“In addition, miR-21 inhibited RECK and TIMP3 genes to mediate A172 glioma cell, Hela cervical carcinoma cell and MCF-7 cell invasion ability (6).”
InfluentialClinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer
Rachagani, S., Macha, M. A., Heimann, N., Seshacharyulu, P., Haridas, D., Chugh, S., & Batra, S. K. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.020 · Cited by 107
“metastasis and invasion of glioma [275], neuroblastoma [276] andmelanoma [277] respectively.”
BackgroundEffect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells
Quintavalle, C., Donnarumma, E., Iaboni, M., Roscigno, G., Garofalo, M., Romano, G., Fiore, D., Marinis, P. D., Croce, C. M., & Condorelli, G. (2012) · Oncogene · doi:10.1038/onc.2012.410 · Cited by 106
del Campo, S. E. M., Latchana, N., Levine, K. M., Grignol, V. P., Fairchild, E. T., Jaime‐Ramirez, A. C., Dao, T.-V., Karpa, V. I., Carson, M. Y., Ganju, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115919 · Cited by 110
“Decreased expression of TIMP3 in response to increased miR-21 was first described in cholangiocarcinoma and glioma [19, 20].”
BackgroundResultInfluential
Metadata
- Authors
- Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Regulus Therapeutics (United States) (US)
- Corresponding author
- Krichevsky, Anna M.
- ORCID
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-09-01
- Volume
- 28
- Issue
- 17
- Pages
- 5369-5380
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2519720
- OpenAlex
- W2163655902
- Cited by
- 888
- References
- 62
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 21 · 2023: 29 · 2022: 20 · 2021: 21 · 2020: 43 · 2019: 41 · 2018: 33 · 2017: 56 · 2016: 56 · 2015: 75 · 2014: 76 · 2013: 86 · 2012: 91
- FWCI
- 21.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- PubMed Central (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Institutes of Health (CA86355)
- National Cancer Institute (R21 CA116141, P50 CA86355-04, P50CA086355)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- miR-21, glioma invasion, glioblastoma, matrix metalloproteinases, RECK, TIMP-3, matrix metalloproteinase inhibitors, cell migration, apoptosis, antisense oligonucleotides, microRNA inhibition, tumor malignancy
- MeSH terms
- Animals, Base Sequence, Cell Movement, Enzyme Inhibitors, Extracellular Matrix, Glioma, Humans, Molecular Sequence Data, Neoplasm Invasiveness, Neoplasm Transplantation, RNA, Messenger, Down-Regulation, Gene Expression Regulation, Neoplastic, Apoptosis, Disease Progression, Oligonucleotide Array Sequence Analysis, Matrix Metalloproteinases, Gene Expression Profiling, MicroRNAs, Cell Line, Tumor, Mice, Genes, Neoplasm, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review